Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Pinto

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
The International Journal of Biological Markers|January 10, 2006
Prognostic biomarkers in renal cell carcinoma: relevance of DNA ploidy in predicting disease-related survivalA E Pinto, P Monteiro, G Silva, et al.
Acta Oncologica (Stockholm, Sweden)|August 16, 2001
Male breast cancer--a reappraisal of clinical and biologic indicators of prognosisS André, I Fonseca, A E Pinto, et al.
Journal of Medicinal Chemistry|July 18, 2013
Highly potent and selective nonsteroidal dual inhibitors of CYP17/CYP11B2 for the treatment of prostate cancer to reduce risks of cardiovascular diseasesMariano A E Pinto-Bazurco Mendieta, Qingzhong Hu, Matthias Engel, et al.
Diseases of the Colon and Rectum|April 1, 1997
Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinomaA E Pinto, P Chaves, P Fidalgo, et al.
Clinical Neuropathology|June 13, 1998
Clear cell meningioma variant and clinical aggressivenessJ Pimentel, A Fernandes, A E Pinto, et al.
Cancer|January 28, 1999
Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progressionJ Soares, A E Pinto, C V Cunha, et al.
Journal of Medicinal Chemistry|August 5, 2008
Synthesis, biological evaluation, and molecular modeling of abiraterone analogues: novel CYP17 inhibitors for the treatment of prostate cancerMariano A E Pinto-Bazurco Mendieta, Matthias Negri, Carsten Jagusch, et al.
British Journal of Cancer|April 30, 2009
Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomasM M Moura, B M Cavaco, A E Pinto, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Synthesis, biological evaluation and molecular modelling studies of novel ACD- and ABD-ring steroidomimetics as inhibitors of CYP17Mariano A E Pinto-Bazurco Mendieta, Matthias Negri, Carsten Jagusch, et al.
Archiv Der Pharmazie|August 23, 2008
CYP17 inhibitors. Annulations of additional rings in methylene imidazole substituted biphenyls: synthesis, biological evaluation and molecular modellingMariano A E Pinto-Bazurco Mendieta, Matthias Negri, Qingzhong Hu, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
The International Journal of Biological Markers|January 10, 2006
Prognostic biomarkers in renal cell carcinoma: relevance of DNA ploidy in predicting disease-related survivalA E Pinto, P Monteiro, G Silva, et al.
Acta Oncologica (Stockholm, Sweden)|August 16, 2001
Male breast cancer--a reappraisal of clinical and biologic indicators of prognosisS André, I Fonseca, A E Pinto, et al.
Journal of Medicinal Chemistry|July 18, 2013
Highly potent and selective nonsteroidal dual inhibitors of CYP17/CYP11B2 for the treatment of prostate cancer to reduce risks of cardiovascular diseasesMariano A E Pinto-Bazurco Mendieta, Qingzhong Hu, Matthias Engel, et al.
Diseases of the Colon and Rectum|April 1, 1997
Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinomaA E Pinto, P Chaves, P Fidalgo, et al.
Clinical Neuropathology|June 13, 1998
Clear cell meningioma variant and clinical aggressivenessJ Pimentel, A Fernandes, A E Pinto, et al.
Cancer|January 28, 1999
Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progressionJ Soares, A E Pinto, C V Cunha, et al.
Journal of Medicinal Chemistry|August 5, 2008
Synthesis, biological evaluation, and molecular modeling of abiraterone analogues: novel CYP17 inhibitors for the treatment of prostate cancerMariano A E Pinto-Bazurco Mendieta, Matthias Negri, Carsten Jagusch, et al.
British Journal of Cancer|April 30, 2009
Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomasM M Moura, B M Cavaco, A E Pinto, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Synthesis, biological evaluation and molecular modelling studies of novel ACD- and ABD-ring steroidomimetics as inhibitors of CYP17Mariano A E Pinto-Bazurco Mendieta, Matthias Negri, Carsten Jagusch, et al.
Archiv Der Pharmazie|August 23, 2008
CYP17 inhibitors. Annulations of additional rings in methylene imidazole substituted biphenyls: synthesis, biological evaluation and molecular modellingMariano A E Pinto-Bazurco Mendieta, Matthias Negri, Qingzhong Hu, et al.
Pageof 5